- Home
- NOAH vs TERN Comparison
NOAH vs TERN Comparison
Compare NOAH & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOAH
- TERN
- Stock Information
- Founded
- NOAH 2005
- TERN 2017
- Country
- NOAH China
- TERN United States
- Employees
- NOAH N/A
- TERN N/A
- Industry
- NOAH Investment Managers
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- NOAH Finance
- TERN Health Care
- Exchange
- NOAH Nasdaq
- TERN Nasdaq
- Market Cap
- NOAH 683.3M
- TERN 710.6M
- IPO Year
- NOAH 2010
- TERN 2021
- Fundamental
- Price
- NOAH $10.30
- TERN $26.28
- Analyst Decision
- NOAH Buy
- TERN Buy
- Analyst Count
- NOAH 1
- TERN 11
- Target Price
- NOAH $11.50
- TERN $22.79
- AVG Volume (30 Days)
- NOAH 80.5K
- TERN 5.4M
- Earning Date
- NOAH 11-25-2025
- TERN 11-10-2025
- Dividend Yield
- NOAH 5.67%
- TERN N/A
- EPS Growth
- NOAH N/A
- TERN N/A
- EPS
- NOAH 0.75
- TERN N/A
- Revenue
- NOAH $360,100,505.00
- TERN N/A
- Revenue This Year
- NOAH N/A
- TERN N/A
- Revenue Next Year
- NOAH $5.17
- TERN N/A
- P/E Ratio
- NOAH $13.67
- TERN N/A
- Revenue Growth
- NOAH N/A
- TERN N/A
- 52 Week Low
- NOAH $7.67
- TERN $1.87
- 52 Week High
- NOAH $13.30
- TERN $28.49
- Technical
- Relative Strength Index (RSI)
- NOAH 28.46
- TERN 80.56
- Support Level
- NOAH $10.52
- TERN $7.87
- Resistance Level
- NOAH $10.87
- TERN $28.49
- Average True Range (ATR)
- NOAH 0.23
- TERN 2.03
- MACD
- NOAH -0.07
- TERN 0.73
- Stochastic Oscillator
- NOAH 11.90
- TERN 83.22
About NOAH Noah Holdings Limited
Noah Holdings Ltd is a wealth management service provider offering comprehensive advisory services on investment and asset allocation, mainly for Mandarin-speaking high-net-worth (HNW) investors. The company's operating segments are Domestic public securities, Domestic asset management, Domestic insurance, Overseas wealth management, Overseas asset management, Overseas insurance and comprehensive services, and Headquarters. Maximum revenue is generated from its Domestic asset management business, which manages private equity funds, real estate equity funds, and private secondary products. The domestic asset management operations focus on managing primary market exits and cross-border ETF products in the secondary market. Geographically, it derives maximum revenue from Mainland China.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.